Helius to showcase PoNS device at annual PT meeting Feb. 15-17

For general inquiries, call 1 877-564-0008 or [email protected]. Fax PoNS device prescriptions to 1 (215) 754-4903.

Join Helius at this year’s CSM in Boston, MA, and learn more about PoNS Therapy.

Note: The device has been authorized in Australia as a non-implantable neurostimulator intended for short-term use by healthcare professionals as an adjunct to a therapeutic exercise program to improve balance and gait. It is not yet commercially available in Australia.

For Patients

For general inquiries, contact us by phone at 1 877-564-0008 or via email at [email protected].

Please fax PoNS device prescriptions to 1 (215) 754-4903.

NASDAQ: HSDT

Indications

The PoNS^® device is indicated for use as a short term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis and is to be used as an adjunct to a supervised therapeutic exercise program for adults 22 years of age and over by prescription only.

Contraindications

The PoNS^® device delivers electrical stimulation directly to the surface of the tongue. Precautions for use are similar to those for transcutaneous electrical nerve stimulation (TENS).

Electrical stimulation should not be used:

If there is an active or suspected malignant tumor
In areas of recent bleeding or open wounds
In areas that lack normal sensation

The PoNS^® has not been tested on, and thus should not be used by individuals who are pregnant. Do not use the PoNS^® if you are sensitive to nickel, gold or copper.

Helius to showcase PoNS device at annual PT meeting Feb. 15-17

For Patients

Indications

Contraindications

Ready to get started with PoNS?